Type:
Whole Allergen
Whole Allergen
Whole Allergen
European ash
Inhalation
Oleaceae
Fraxinus excelsior
Fraxinus excelsior
Ash
European ash trees (Fraxinus excelsior) are distributed across temperate regions of Europe, North America and central Asia. Fraxinus pollen is a potent allergen source causing asthma, allergic rhinoconjunctivitis and potentially urticaria and allergic dermatitis. Ash pollen shares structural and allergenic similarities with other members of the Oleaceae (olive) family, although there is conflicting evidence for cross-reactivity with olive tree pollen.
The European ash is a deciduous tree of temperate regions, widely distributed across most of Europe except northern Scandinavia and the southern Mediterranean (1). It is also found in North America and in central Asia, including central and southern Russia, Iran, Iraq and Turkey (2, 3).
Fraxinus pollen is wind-borne (2). Peak pollen counts are seen in April in the UK, with a medium-high emissions strength compared to other common tree pollens (4). In north-western Spain, Fraxinus flowers during the winter (December to March/early April) and ash pollen constitutes about 2% of total airborne pollen (5). In north-eastern Iran, ash was among the most prevalent aeroallergens seen in all seasons of the year (6). Ash was also the leading tree pollen allergen in a 2015 study of aeroallergens in Istanbul (7).
Fraxinus pollen counts fall during periods of rainfall and high humidity, when pollen grains are removed from the air to the ground. Fraxinus allergen concentrations correlate with high air temperature but also with rainfall, as the osmotic pressure of water tends to explode pollen grains, releasing submicronic protein particles into the atmosphere (5).
Taxonomic tree of Fraxinus genus (2) |
|
Domain |
Eukaryota |
Kingdom |
Plantae |
Phylum |
Spermatophyta |
Subphylum |
Angioospermae |
Class |
Dicotyledonae |
Family |
Oleaceae |
Genus |
Fraxinus |
Tree pollen.
Fraxinus excelsior is a broad-leaved tree common in many types of forest throughout Europe. It has a high economic value due to its fast growth and outstanding wood properties (8). European ash is used as an ornamental tree in Spanish cities (9).
The main route of exposure is inhalation.
Ash pollen is sampled using a vacuum air sampler such as the Burkard volumetric spore sampler (10) or the Hirst-type pollen trap (11).
European ash is a potent allergen source (3) and a common cause of allergic rhinitis, conjunctivitis and asthma (6, 12). The prevalence of ash pollen sensitization in Germany is about 10%, although it may be underestimated because the ash pollination season in Europe overlaps with birch (Betulaceae) (13). In a study of 5416 Austrian patients sensitized to any pollen, 17.6% had a positive skin prick test to ash (14). In northern Iran, 36.7% of 1006 allergic patients showed a positive skin prick test to Fraxinus excelsior; this was significantly associated with asthma and allergic rhinitis, although urticaria and atopic dermatitis were also recorded (6). In a New York study, 27% of 371 allergic patients were sensitized to ash (3), while in Istanbul, 8.1% of 60 allergic patients showed a positive skin prick test to ash, which was the main sensitizer among the woody plants tested (7).
In a Belgian study comparing pollen exposure and sales of allergic rhinitis medication, positive associations were found between Fraxinus pollen counts and medication sales (10).
In nasal provocation tests, 58% of 113 ash-sensitized patients showed symptoms of allergy, while 42% were clinically silent. 94% of sensitized patients and 88% of allergic patients were poly-sensitized to three or more allergens in addition to ash pollen, and 86% of all patients also had a positive skin prick test to birch (Betulaceae) pollen (13).
Testing ash sensitization using specific IgE to native ash extract is almost as effective as the skin prick test (SPT), with 98% of 113 SPT-positive patients showing specific IgE (13).
One study suggests that better standardized or more widely available olive pollen extracts may be used instead of ash pollen extract for allergen-specific immunotherapy (12); this is not supported by a more recent study (13).
Avoidance
Allergenic vegetation maps may contribute to allergy risk assessments by showing the location of ash trees at 1 km resolution. They can be combined with health data to inform allergy research, or with weather data to improve pollen forecasting or to generate pollen emission models (4). Fraxinus allergy risk periods can also be forecasted using regression equations of pollen count, rainfall and temperature (5).
Allergenic molecules of Fraxinus excelsior (15-17)
Allergen name |
Biochemical name/protein group (where known) |
Fra e 1 |
Ole e 1-like protein family member |
Fra e 2 |
Profilin |
Fra e 3 |
Calcium-binding protein (polcalcin) |
Fra e 6 |
- |
Fra e 7 |
- |
Fra e 9 |
ß-1,3-Glucanase |
Fra e 11 |
- |
Fra e 12 |
- |
Fra e 1 is the major pollen allergen of Fraxinus excelsior. It belongs to the olive tree (Ole e 1) protein family and shows a high degree of homology with other Oleaceae proteins (3, 5). Fra e 1 exhibits 82%, 88%, and 91% amino acid sequence identity with lilac (Syr v 1), olive (Ole e 1), and privet (Lig v 1), respectively (3).
Extensive immunological cross-reactivity between olive, ash and privet pollen may lead to poly-sensitization of susceptible patients due to the priming effect (5, 9). Cross-reactivity between the main allergens of Fraxinus and Olea species has been demonstrated by using Ole e 1 (olive) antibodies to detect Fra e 1 (ash) allergens in the atmosphere (9). One study found that determining specific IgE to Ole e 1 was as effective at diagnosing ash pollen allergy as determining IgE to Fra e 1 (Imhof et al. 2014), whereas another concluded that in countries where sensitization to ash does not occur via the olive tree, testing for component olive allergens (rOle e 1, nOle e 7, rOle e 9) will not reliably identify ash sensitization and allergy (13). There is very limited cross-reactivity between ash and birch pollen allergens (12).
Author: RubyDuke Communications
Reviewer: Dr. Christian Fischer
Last reviewed:February 2022